Fluvastatin: efficacy and safety in reducing cardiac events

Abstract

The importance of statin therapy in lipid-lowering and its role in primary and secondary prevention has been borne out of numerous clinical trials conducted over the last two decades. Concurrently, much concern has been expressed over the safety and tolerability of these drugs. Fluvastatin has demonstrated good clinical efficacy and safety. This paper reviews the various pharmacological properties and evidence supporting its use in the prevention of cardiac events.

Keywords::

• clinical trials
• fluvastatin
• pharmacodynamics
• pharmacokinetics
• safety